Literature DB >> 26270540

Health care expenditures associated with depression in adults with cancer.

Xiaoyun Pan1, Usha Sambamoorthi2.   

Abstract

BACKGROUND: The rates of depression in adults with cancer have been reported as high as 38%-58%. How depression affects overall health care expenditures in individuals with cancer is an under-researched area.
OBJECTIVE: To estimate excess average total health care expenditures associated with depression in adults with cancer by comparing those with and without depression after controlling for demographic, socioeconomic, access to care, and other health status variables.
METHODS: Cross-sectional data on 4,766 adult survivors of cancer from 2006-2009 of the nationally representative household survey, Medical Expenditure Panel Survey (MEPS), were used. The patients were older than 21 years. Cancer and depression were identified from the patients' medical conditions files. Dependent variables consisted of total, inpatient, outpatient, emergency department, prescription drugs, and other expenditures. Ordinary least square (OLS) on logged dollars and generalized linear models with log-link function were performed. All analyses (SAS 9.3 and STATA12) accounted for the complex survey design of the MEPS.
RESULTS: Overall, 14% of individuals with cancer reported having depression. In those with cancer and depression, the average annual health care expenditures were $18,401 compared with $12,091 in those without depression. After adjusting for demographic, socioeconomic, access to care, and other health status variables, those with depression had about 31.7% greater total expenditures compared with those without depression. Total, outpatient, and prescription expenditures were higher in individuals with depression than in those without depression. Individuals with cancer and depression were significantly more likely to use emergency departments (adjusted odds ratio, 1.46) compared with their counterparts without depression. LIMITATIONS: Cancer patients who died during the reporting year were excluded. The financial burden of depression may have been underestimated because the costs of end-of-life care are high. The burden for each cancer type was not analyzed because of the small sample size.
CONCLUSION: In adults with cancer, those with depression had higher health care utilization and expenditures compared with those without depression. FUNDING/SPONSORSHIP: One author was partially supported by the National Institute of General Medical Sciences, U54GM104942. ©2015 Frontline Medical Communications.

Entities:  

Keywords:  cancer; depression; expenditure

Year:  2015        PMID: 26270540      PMCID: PMC4576451          DOI: 10.12788/jcso.0150

Source DB:  PubMed          Journal:  J Community Support Oncol        ISSN: 2330-7749


  34 in total

1.  Estimating log models: to transform or not to transform?

Authors:  W G Manning; J Mullahy
Journal:  J Health Econ       Date:  2001-07       Impact factor: 3.883

Review 2.  A review of the relationship between depression and diabetes in adults: is there a link?

Authors:  F Talbot; A Nouwen
Journal:  Diabetes Care       Date:  2000-10       Impact factor: 19.112

3.  Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence.

Authors:  M R DiMatteo; H S Lepper; T W Croghan
Journal:  Arch Intern Med       Date:  2000-07-24

4.  Influence of psychological response on survival in breast cancer: a population-based cohort study.

Authors:  M Watson; J S Haviland; S Greer; J Davidson; J M Bliss
Journal:  Lancet       Date:  1999-10-16       Impact factor: 79.321

5.  Cost-effectiveness of a collaborative care program for primary care patients with persistent depression.

Authors:  G E Simon; W J Katon; M VonKorff; J Unützer; E H Lin; E A Walker; T Bush; C Rutter; E Ludman
Journal:  Am J Psychiatry       Date:  2001-10       Impact factor: 18.112

6.  Competing demands from physical problems: effect on initiating and completing depression care over 6 months.

Authors:  P A Nutting; K Rost; J Smith; J J Werner; C Elliot
Journal:  Arch Fam Med       Date:  2000 Nov-Dec

7.  Psychological distress following first recurrence of disease in patients with breast cancer: prevalence and risk factors.

Authors:  H Okamura; T Watanabe; M Narabayashi; N Katsumata; M Ando; I Adachi; T Akechi; Y Uchitomi
Journal:  Breast Cancer Res Treat       Date:  2000-05       Impact factor: 4.872

8.  Cost-effectiveness of systematic depression treatment for high utilizers of general medical care.

Authors:  G E Simon; W G Manning; D J Katzelnick; S D Pearson; H J Henk; C S Helstad
Journal:  Arch Gen Psychiatry       Date:  2001-02

9.  Comorbid medical conditions among depressed elderly patients discharged home after acute psychiatric care.

Authors:  Enola K Proctor; Nancy L Morrow-Howell; Peter Doré; Joan Wentz; Eugene H Rubin; Sana Thompson; Hong Li
Journal:  Am J Geriatr Psychiatry       Date:  2003 May-Jun       Impact factor: 4.105

10.  Psychiatric morbidity and its recognition by doctors in patients with cancer.

Authors:  L Fallowfield; D Ratcliffe; V Jenkins; J Saul
Journal:  Br J Cancer       Date:  2001-04-20       Impact factor: 7.640

View more
  19 in total

Review 1.  The impact of chronic conditions on the economic burden of cancer survivorship: a systematic review.

Authors:  Sun Hee Rim; Gery P Guy; K Robin Yabroff; Kathleen A McGraw; Donatus U Ekwueme
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2016-10-06       Impact factor: 2.217

2.  Depression treatment and healthcare expenditures among elderly Medicare beneficiaries with newly diagnosed depression and incident breast, colorectal, or prostate cancer.

Authors:  Monira Alwhaibi; Usha Sambamoorthi; Suresh Madhavan; James T Walkup
Journal:  Psychooncology       Date:  2017-01-24       Impact factor: 3.894

3.  Spending on Hospital Care and Pediatric Psychology Service Use Among Adolescents and Young Adults With Cancer.

Authors:  Meghan E McGrady; James L Peugh; Gabriella A Brown; Ahna L H Pai
Journal:  J Pediatr Psychol       Date:  2017-10-01

4.  Depression and Health Care Utilization at End of Life Among Older Adults With Advanced Non-Small-Cell Lung Cancer.

Authors:  Cara L McDermott; Aasthaa Bansal; Scott D Ramsey; Gary H Lyman; Sean D Sullivan
Journal:  J Pain Symptom Manage       Date:  2018-08-17       Impact factor: 3.612

5.  Impact of depression treatment on health-related quality of life among adults with cancer and depression: a population-level analysis.

Authors:  Ami Vyas; Zachary Babcock; Stephen Kogut
Journal:  J Cancer Surviv       Date:  2017-08-10       Impact factor: 4.442

6.  Comparing the Mental Health of Sexual Minority and Heterosexual Cancer Survivors: A Systematic Review.

Authors:  Janna R Gordon; Sharon H Baik; Karen T G Schwartz; Kristen J Wells
Journal:  LGBT Health       Date:  2019-07-17       Impact factor: 4.151

7.  Multimorbidity and Employment Outcomes Among Middle-Aged US Cancer Survivors.

Authors:  Christine C Ekenga; BoRin Kim; Eunsun Kwon; Sojung Park
Journal:  J Occup Environ Med       Date:  2022-06-01       Impact factor: 2.306

Review 8.  Systematic review of healthcare costs related to mental health conditions among cancer survivors.

Authors:  Jaya S Khushalani; Jin Qin; John Cyrus; Natasha Buchanan Lunsford; Sun Hee Rim; Xuesong Han; K Robin Yabroff; Donatus U Ekwueme
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2018-06-20       Impact factor: 2.217

9.  The Relationship of Post-traumatic Stress Disorder to End-of-life Care Received by Dying Veterans: a Secondary Data Analysis.

Authors:  Kathleen E Bickel; Richard Kennedy; Cari Levy; Kathryn L Burgio; F Amos Bailey
Journal:  J Gen Intern Med       Date:  2019-12-02       Impact factor: 5.128

10.  Mental Health Outcomes in Adolescent and Young Adult Female Cancer Survivors of a Sexual Minority.

Authors:  Milli J Desai; Rebecca S Gold; Chelsea K Jones; Hena Din; Andrew C Dietz; Ksenya Shliakhtsitsava; Maria Elena Martinez; Florin Vaida; Hui-Chun Irene Su
Journal:  J Adolesc Young Adult Oncol       Date:  2020-07-27       Impact factor: 2.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.